Tysabri Side Effects Linked to 9th PML Infection Case

|
AboutLawsuits

Add Your Comments

A new case of a rare, often lethal, brain infection has been linked to the multiple sclerosis drug Tysabri, making it the ninth case of progressive multifocal leukoencephalopathy (PML) infection potentially caused by side effects of Tysabri since the drug was put back on the market in July 2006.

Biogen Idec Inc., the maker of Tysabri, reported the case on Friday, one week after the eighth case was reported. The company indicates that they will no longer report each individual cases of Tysabri PML infections, but will provide a weekly update on their website.

Progressive multifocal leukoencephalopathy, commonly referred to as PML, is a rare form of brain infection that causes damage and inflammation to the white matter areas of the brain. The infection often results in death after the degradation of certain brain functions. Affects of the infection can include impaired speech, weakness, loss of vision, paralysis and cognitive decline.

Do You Know about…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION
Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Do You Know About…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION

Tysabri (natalizumab) was approved in 2004 for the treatment of multiple sclerosis through regular intravenous injections. It was recalled from the market in 2005 after three patients developed the rare brain infection, two of whom died. The medication was reintroduced in July 2006 with stronger warnings about the potential Tysabri side effects, and the drug was only made available under strict usage guidelines to limit the risk of PML infections.

Since its return to the market, this most recent report is at least the ninth patient to develop the infection. Estimates indicate that about one in every 1,000 patients treated with the Tysabri experience the side effect. The lastest case involves a patient outside the United States who developed the brain infection after his 34th injection.

Tysabri is just one of several drugs that have been linked to the deadly PML brain infections in recent years. The psoriasis drug Raptiva was recalled in April due to PML infections, and the cancer drug Rituxan was recently connected to 57 cases of PML infection in a study published in the May 2009 issue of the medical journal Blood.

Tags: Brain Infection, Infection, Multiple Sclerosis, PML, Psoriasis, Raptiva, Rituxan, Tysabri
Image Credit: |

More Lawsuit Stories

1 Comments

Lyudmila
When my doctor intllaiiy told me last November that Copaxone wasn’t doing enough to treat my MS and that he wanted me to go on Tysabri or Gilenya I was very tempted to go on Gilenya. Especially when I found out I have the JC virus (this virus increases your chances of getting PML on Tysabri). The main reason why I chose Tysabri last December was because Gilenya had only been on the market for a month or two and I was scared on it being such a new drug and that the people in the trials had only been on it for a year or two. I decided to go on Tysabri but for only a year and then I would change treatments. Next week I will have my 12th Tysabri influsion and I plan for it to be my last as I just don’t want to take the risk of getting PML. I plan to start on Gilenya sometime in 2012 so I don’t know much about it effecting people being active but I will repost your question and maybe someone else may have some experience. From the comments and feedback I have seen about Gilenya it appears people mainly complain of headaches at the begining but do better as they are on it longer.Thanks for the comment and question!

This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Judge Says Suboxone 'Schedule A' Lawsuits Should Be Filed Individually or Dismissed
Two years after allowing thousands of incomplete Suboxone tooth decay lawsuits to be submitted due to statutes of limitation laws, a federal judge says those cases should be filed individually or dismissed.
JPML Sets Hearing Over Spinal Cord Stimulator Lawsuit Consolidation For May 28
In late May, a panel of federal judges will hold oral arguments over whether all federal spinal cord stimulator lawsuits should be consolidated before one judge for pretrial proceedings.
Fire Pit Burn Lawsuits Mount as CPSC Issues Warning Over New Flame Jetting Injuries, Death
As the number of lawsuits over tabletop fire pits continues to grow, the CPSC has issued a warning indicating that despite a consumer’s death linked to one product, the manufacturer has not agreed to remove the devices from the market.